Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- Check4 days agoChange DetectedA new revision entry (v3.5.5) has been added to the record history, and the previous revision entry (v3.5.4) has been removed from the list.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry, v3.5.4, was added to the study's record history, indicating an updated version of the record and replacing the previous v3.5.3 in the history timeline.SummaryDifference0.1%

- Check47 days agoChange DetectedA site interface revision marker was updated from version v3.5.2 to v3.5.3, reflecting a non-content update to the page’s release/build labeling.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record history now includes a new revision entry (v3.5.2) and removes the older revision (v3.5.0).SummaryDifference0.1%

- Check83 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the history page.SummaryDifference0.1%

- Check90 days agoChange DetectedA new revision entry v3.4.3 (2026-03-11) was added to the Record History, and the previous revision v3.4.2 (2025-12-30) was listed in deletions.SummaryDifference0.5%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.